SELLAS Life Sciences Group, Inc. Sale of Stock, Price Per Share
SELLAS Life Sciences Group, Inc. (SLS) had Sale of Stock, Price Per Share of $25.00 per share as of 2019-06-18, per its 10-K filed 2021-03-23.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2021-03-23
- 2019-06-18: Sale of Stock, Price Per Share $25.00; Sale of Stock, Price Per Share as first filed $0.50.
- 2018-07-16: Sale of Stock, Price Per Share $105.00; Sale of Stock, Price Per Share as first filed $2.10.
- 2017-12-31: Sale of Stock, Price Per Share $7.86.
| Period end | Sale of Stock, Price Per Share | Sale of Stock, Price Per Share as first filed |
|---|---|---|
| 2019-06-18 | $25.00 10-K · filed 2021-03-23 | $0.50 10-Q · filed 2019-08-14 |
| 2018-07-16 | $105.00 10-K · filed 2020-03-13 | $2.10 10-Q · filed 2018-11-14 |
| 2017-12-31 | $7.86 10-K · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |